Melissa Lin
Finance Editor, Toptal
Melissa is an Editor for the Finance blog, contributing to the publication's growth and development. She has experience in finance, management consulting, and business development at tech startups, and graduated from Cornell University with a BSc in Industrial & Labor Relations.
Articles by Melissa Lin
Big Data: Prescription for the Pharmaceutical R&D Plight
Big Data: Prescription for the Pharmaceutical R&D Plight
Pharma R&D is a notoriously long and arduous process, and it can take more than 10 years and $2.6 billion to bring a single drug to market. Among the biggest players, the return on investment for R&D fell to 3.7% in 2016. However, a solution could be data analytics, which enhances and accelerates drug development. This article examines the current state of drug development, and how big data can improve its different components: drug discovery, clinical trial design, and adverse drug reaction detection.